Bridget Martell A.'s most recent trade in Aligos Therapeutics Inc was a trade of 5,860 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aligos Therapeutics Inc | Bridget A. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 5,860 | 5,860 | - | - | Stock Option (Right to Buy) | |
| Achieve Life Sciences Inc. | Bridget A. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Aligos Therapeutics Inc | Bridget A. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Bridget Martell A. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2024 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Aligos Therapeutics Inc | Bridget A. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 8,823 | 8,823 | - | - | Stock Option (Right to Buy) | |
| Achieve Life Sciences Inc. | Martell A. Bridget | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc. | Bridget A. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Aligos Therapeutics Inc | Bridget A. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Achieve Life Sciences Inc. | Bridget A. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc. | Bridget A. Martell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 5,650 | 5,650 | - | - | Stock Option (right to buy) |